Filter posts

Commonsense Solutions to Lower Drug Costs

With a national debate underway over drug prices, people are looking for ways to help …

BIO Statement on SCOTUS Biosimilar Products Ruling

On Monday the United States Supreme Court issued a decision in Sandoz, Inc. v. Amgen, …

A Cheat Sheet for Today’s Drug Price Hearing

The debate over drug pricing is heating up in various states across the country. But …

#BIO2017: What's Happening in the World of IP?

Who’s ready to hit the beach? Wait, did I say beach? I meant the San …

BIO Reacts to Supreme Court opinion in Impression Products, Inc. v. Lexmark International, Inc.

On Tuesday, May 30, 2017, the U.S. Supreme Court issued an opinion in  Impression Products, Inc. …

USTR’s Report Targets Trade Barriers to Biotech

The Office of the United States Trade Representative’s (USTR) annual Special 301 Report identifies trade …

IRS Issues Guidance on Start-up R&D Credit

At the end of March, the IRS issued interim guidance explaining how eligible small businesses …

Jim Greenwood Celebrates JOBS Act Turning Five (Op-Ed in The Hill)

Five years ago today, the Jumpstart Our Business Startups (JOBS) Act became law. The JOBS …

BIO Chimes In: TC Heartland LLC v. Kraft Food Brands Group LLC (Supreme Court)

This is part two of a three part series on BIO’s recently submitted amicus briefs in cases …

Four Former FDA Commissioners Warn About Drug Importation Dangers

Last week, four former FDA Commissioners – Robert M. Califf, Margaret B. Hamburg, Mark B. …